Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

897
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
897
Humoral Immune Responses01:36

Humoral Immune Responses

71.2K
Overview
71.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

66.7K
Overview
66.7K
What is the Immune System?01:38

What is the Immune System?

110.1K
Overview
110.1K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

11.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Laying the foundation in food allergy education: CSACI food allergy educator program.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same author

Summarizing the 2024 immunotherapy manual of the Canadian society of allergy and clinical immunology.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same author

Reply.

The Journal of allergy and clinical immunology·2026
Same author

The economic value of self-administered subcutaneous immunoglobulin G (SCIg) in Canada: a scoping review.

Journal of medical economics·2026
Same author

Risk Factors for the Development of Food Allergy in Infants and Children: A Systematic Review and Meta-Analysis.

JAMA pediatrics·2026
Same author

The International/Canadian hereditary angioedema guideline.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

A qualitative study of the impact of the COVID-19 pandemic on healthcare access and service delivery for people living with chronic obstructive pulmonary disease and asthma.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Preventive effect of heat-killed Lactiplantibacillus plantarum FM8 in an ovalbumin-induced food allergy murine model.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Mepolizumab reduces healthcare resource utilization in patients with chronic rhinosinusitis with nasal polyps: a linked EMR and claims-based pre-post study.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Triggers, clinical spectra and outcomes of pediatric anaphylaxis in a tertiary center: impact of comorbidities and cofactors on severity.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Declining venom immunotherapy: patient characteristics and clinical outcomes.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
Same journal

Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2026
See all related articles

Related Experiment Video

Updated: May 30, 2025

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.6K

Secondary Immunodeficiency.

Persia Pourshahnazari1, Stephen D Betschel2, Vy H D Kim3,4

  • 1Division of Allergy and Immunology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. persia.nazari@gmail.com.

Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
|January 28, 2025
PubMed
Summary
This summary is machine-generated.

New medical advances can lead to secondary immunodeficiencies (SID), increasing infection risks. This primer reviews common causes, assessment, and management strategies for patients with SID.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K

Related Experiment Videos

Last Updated: May 30, 2025

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.6K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

8.9K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.2K

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pharmacology

Background:

  • Medical advancements lead to longer patient lifespans and evolving therapies.
  • Some novel treatments can adversely affect the immune system.
  • Secondary immunodeficiencies (SID) increase susceptibility to infections and complications.

Purpose of the Study:

  • To provide an overview of conditions and therapies causing SID.
  • To guide healthcare providers in assessing and managing patients with SID.

Main Methods:

  • Review of common conditions leading to SID.
  • Discussion of therapeutic options associated with SID.
  • Guidance on patient assessment and management.

Main Results:

  • Identification of various medical conditions and treatments contributing to SID.
  • Understanding the broad range of causes and consequences of SID.
  • Framework for clinical evaluation and therapeutic strategies for SID.

Conclusions:

  • Healthcare providers must be aware of potential adverse effects of new therapies.
  • Secondary immunodeficiencies are a significant concern in modern medicine.
  • Effective assessment and management are crucial for patients with SID.